Making the Most out of Mendel's Laws in Complex Coronary Artery Disease

J Am Coll Cardiol. 2018 Jul 17;72(3):311-313. doi: 10.1016/j.jacc.2018.05.016. Epub 2018 Jul 9.

Authors

Themistocles L Assimes¹, Paul S de Vries²

Affiliations

¹ Department of Medicine, Stanford University School of Medicine, Stanford, California. Electronic address: tassimes@stanford.edu.
² Human Genetics Center, Department of Epidemiology, Human Genetics, and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas.

PMID: 30012325
DOI: 10.1016/j.jacc.2018.05.016

No abstract available

Keywords: Mendelian randomization; biomarkers; causal inference; coronary artery disease; epidemiology; instrumental variable; plasma proteomics.

Publication types

Editorial
Comment

MeSH terms

Chemokine CXCL12
Coronary Artery Disease*
Humans
Mendelian Randomization Analysis

Substances

CXCL12 protein, human
Chemokine CXCL12